171 related articles for article (PubMed ID: 23717719)
1. [Intermittent preventive treatment with sulfadoxine--pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso].
Bamba S; Séré A; Nikiéma R; Halidou T; Thiéba B; Dao B; Guiguemdé RT
Pan Afr Med J; 2013; 14():105. PubMed ID: 23717719
[TBL] [Abstract][Full Text] [Related]
2. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
Odongo CO; Bisaso RK; Byamugisha J; Obua C
Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
[TBL] [Abstract][Full Text] [Related]
3. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
[TBL] [Abstract][Full Text] [Related]
4. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
Owusu-Boateng I; Anto F
Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
Onyeneho NG; Orji BC; Okeibunor JC; Brieger WR
Int J Gynaecol Obstet; 2013 Nov; 123(2):101-4. PubMed ID: 24041469
[TBL] [Abstract][Full Text] [Related]
6. Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.
Deloron P; Bertin G; Briand V; Massougbodji A; Cot M
Emerg Infect Dis; 2010 Nov; 16(11):1666-70. PubMed ID: 21029522
[TBL] [Abstract][Full Text] [Related]
7. Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?
Gutman J; Slutsker L
Am J Trop Med Hyg; 2017 Jan; 96(1):9-10. PubMed ID: 27994102
[No Abstract] [Full Text] [Related]
8. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
[TBL] [Abstract][Full Text] [Related]
10. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
[TBL] [Abstract][Full Text] [Related]
11. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
COSMIC Consortium
Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
[TBL] [Abstract][Full Text] [Related]
12. Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Wilson NO; Ceesay FK; Obed SA; Adjei AA; Gyasi RK; Rodney P; Ndjakani Y; Anderson WA; Lucchi NW; Stiles JK
Am J Trop Med Hyg; 2011 Jul; 85(1):12-21. PubMed ID: 21734118
[TBL] [Abstract][Full Text] [Related]
13. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
14. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
[TBL] [Abstract][Full Text] [Related]
15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
16. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
Coulibaly SO; Kayentao K; Taylor S; Guirou EA; Khairallah C; Guindo N; Djimde M; Bationo R; Soulama A; Dabira E; Barry B; Niangaly M; Diakite H; Konate S; Keita M; Traore B; Meshnick SR; Magnussen P; Doumbo OK; ter Kuile FO
Malar J; 2014 Jan; 13():41. PubMed ID: 24484467
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
[TBL] [Abstract][Full Text] [Related]
18. [Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].
Ouédraogo A; Bougouma EC; Diarra A; Konaté AT; Nébié I; Tiono AB; Sirima SB
Med Mal Infect; 2008 Apr; 38(4):180-6. PubMed ID: 18262380
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Kakuru A; Jagannathan P; Muhindo MK; Natureeba P; Awori P; Nakalembe M; Opira B; Olwoch P; Ategeka J; Nayebare P; Clark TD; Feeney ME; Charlebois ED; Rizzuto G; Muehlenbachs A; Havlir DV; Kamya MR; Dorsey G
N Engl J Med; 2016 Mar; 374(10):928-39. PubMed ID: 26962728
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
